EA
CTIC

Emerald Acquisition’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Emerald Acquisition’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$37K Sell
9,930
-11,360
-53% -$41.4K ﹤0.01% 2911
2016
Q2 		$72K Buy
+21,290
New +$97.7K ﹤0.01% 2879

Other funds holding CTIC

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Emerald Acquisition's CTIC Position: Q3 2016 in Review

Emerald Acquisition reduced its CTI BioPharma Corp. (DE) Common Stock (CTIC) stake by 53% in Q3 2016, selling an estimated $41.4K and leaving 9,930 shares worth $37K. The position accounts for ﹤0.01% of the portfolio, ranked #2911.

Emerald Acquisition first reported a position in CTIC in Q2 2016 and has held it in 2 quarters since. The position peaked at $72K in Q2 2016. 61 funds tracked by Wall St. Rank hold CTIC as of Q3 2016.

  • Emerald Acquisition held 9,930 shares of CTI BioPharma Corp. (DE) Common Stock worth $37K as of Q3 2016.
  • Emerald Acquisition sold 11,360 CTI BioPharma Corp. (DE) Common Stock shares in Q3 2016, an estimated $41.4K.
  • CTI BioPharma Corp. (DE) Common Stock made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2911 holding.
  • Emerald Acquisition first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's CTI BioPharma Corp. (DE) Common Stock position peaked at $72K in Q2 2016.
  • 61 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.